Influencing the use of antibiotics in a Chinese pediatric intensive care unit

Pharm World Sci. 2008 Dec;30(6):787-93. doi: 10.1007/s11096-008-9220-9. Epub 2008 May 21.

Abstract

Objectives: To demonstrate the effectiveness of an intervention in antibiotics prescribing, and evaluate the use of antibiotics in the pediatric intensive care unit (PICU) at the Beijing Children's Hospital.

Methods: Our interventions included (1) educating the pediatricians on antibiotics prescribing, (2) applying an antimicrobial spectrum chart, and (3) controlling the prescription of specific antibiotics with the use of a guideline. Nine hundred clinical records, including clinical information and antibiotic usage data, were selected retrospectatively from the PICU admissions during the pre- and post-intervention periods.

Results: In this 5-year survey, the mean rate of antibiotic prescribing was greater than 95% in the PICU. More than 76% of the prescriptions were started empirically. The most frequently used antibiotics were third-generation cephalosporins. After the intervention, we found a reduction in the rate of antibiotic cost/patient/day (P < 0.05); a decrease in the prescription rate of third-generation cephalosporins and macrolides (P < 0.01); an increase in the prescription rate of beta-lactam/beta-lactamase inhibitors and second-generation cephalosporins (P < 0.01); a reduction in the empiric treatment (P < 0.01); and a significant reduction in the incidence rates of bacterial resistance for imipenem-, cefepime-, and ceftazidime-resistant Pseudomonas aeruginosa (P < 0.05), and cefepime-resistant Escherichia coli and Klebsiella pneumoniae (P < 0.01).

Conclusion: Our interventions led to a significant reduction of broad-spectrum antibiotic prescribing associated with the significant reduction in bacterial resistance in the PICU. The implementation of the antibiotics guideline appeared to be effective.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / economics
  • Anti-Bacterial Agents / therapeutic use*
  • Child, Preschool
  • China / epidemiology
  • Drug Costs
  • Drug Resistance, Bacterial*
  • Education, Medical, Continuing
  • Female
  • Hospitals, Pediatric
  • Humans
  • Infant
  • Intensive Care Units, Pediatric
  • Male
  • Practice Guidelines as Topic*
  • Practice Patterns, Physicians' / standards*
  • Retrospective Studies

Substances

  • Anti-Bacterial Agents